Results 71 to 80 of about 88,182,083 (298)

Improving Access to Medication Assisted Treatment for Opioid Use Disorder in a Rural Emergency Department

, 2022
Opioid Use Disorder (OUD) is a growing epidemic throughout the United States and Maine has not been sparred by this. As the Emergency Department is a frequent location for people with OUD to interact with physicians it has been targeted as an opportunity
Grunvald, Warren
core  

Small Intestinal Bacterial Overgrowth Following Gastrointestinal Cancer Surgery: Current Evidence and Future Perspectives

Annals of Gastroenterological Surgery, EarlyView.
ABSTRACT Small intestinal bacterial overgrowth (SIBO) has recently gained increasing attention as a potential cause of postoperative gastrointestinal symptoms following gastrointestinal cancer surgery. Surgical procedures can disrupt normal gastrointestinal physiology through anatomical reconstruction, impaired motility, reduced gastric acid secretion,
Toru Aoyama, Haruhiko Cho, Takaki Yoshikawa   +2 more
wiley   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

The U.S. Should Increase Access to Medication for Opioid Use Disorder Among Incarcerated Individuals [PDF]

, 2023
Opioid Use Disorder (OUD) is among the most common medical diagnoses for people in jails and prisons. Those leaving incarceration without substance use treatment are 40 times more likely than the general public to have a fatal overdose, making it the ...
Nagle, Cody
core   +1 more source

Design and implementation of a cohort study of persons living with HIV infection who are initiating medication treatment for opioid use disorder to evaluate HIV-1 persistence

Contemporary Clinical Trials Communications, 2021
Background: Opioid use disorder (OUD) negatively impacts the HIV continuum of care for persons living with HIV (PLH). Medication treatment for OUD (MOUD) may have differential biological effects in individuals with HIV and OUD.
Alysse Schultheis, Mark Sanchez, Savannah Pedersen, Tassos Kyriakides, Ya-Chi Ho, Yuval Kluger, Sandra A. Springer   +6 more
doaj   +1 more source

Trends in Access to Medications for Opioid Use Disorder

JAMA Health Forum
ImportanceMedicaid, the largest payer for medications for opioid use disorder (MOUD), disenrolled more than 19.1 million individuals by March 2024 after the continuous coverage requirement ended in April 2023—a process termed Medicaid unwinding—but the impact on buprenorphine receipt remains unknown.ObjectiveTo assess the association between Medicaid ...
Gupta, Sumedha, James, Aditya, Miles, Jennifer, Samples, Hillary, Crystal, Stephen, Simon, Kosali   +5 more
openaire   +2 more sources

Use of a Decision Aid in Medication Initiation Among Patients with Opioid Use Disorder and HIV [PDF]

, 2023
Opioid use disorder refers to the maladaptive use of prescribed or illicit opioids. This condition can be treated using pharmacotherapy referred to as medications for opioid use disorder (MOUD), but they are underutilized.
Gateley, Katrina
core  

The EXPLAIN Study: Exploring Arthrogryposis Multiplex Congenita in Adults in Norway — A Description of Demographic, Medical, and Neurological Findings

American Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.
ABSTRACT Arthrogryposis Multiplex Congenita (AMC) encompasses several hundred conditions with diverse genetic, pathophysiological, and clinical origins. The overarching EXPLAIN study explores underlying causes and implications of AMC and represents the largest clinical cohort of adults with AMC reported to date.
My Vuong Hermansen, Kristin Ørstavik, Unni Steen, Mathias Toft, Cathrine Brunborg, Lena Lande Wekre   +5 more
wiley   +1 more source

Medication for Opioid Use Disorder in the Emergency Department

, 2023
The purpose of this article review is to provide an overview of medications for opioid use disorder (MOUD) in the emergency department (ED), including background, best practice, and complications.
Benson, Keith
core   +1 more source

Structural and social changes due to the COVID-19 pandemic and their impact on engagement in substance use disorder treatment services: a qualitative study among people with a recent history of injection drug use in Baltimore, Maryland

Harm Reduction Journal
Background Substance use disorder treatment and recovery support services are critical for achieving and maintaining recovery. There are limited data on how structural and social changes due to the COVID-19 pandemic impacted individual-level experiences ...
Eshan U. Patel, Suzanne M. Grieb, Abigail K. Winiker, Jennifer Ching, Catherine G. Schluth, Shruti H. Mehta, Gregory D. Kirk, Becky L. Genberg   +7 more
doaj   +1 more source